Teva to hold Indivior generic drug launch pending US ruling

Teva to hold Indivior generic drug launch pending US ruling

REUTERS: Teva Pharmaceuticals has agreed to hold off launching its knock-off version of Indivior Plc's blockbuster opioid addiction drug until the resolution of a U.S. Court case on another generic rival, Indivior said on Wednesday.

The pair's Indian rival Dr.Reddy's Laboratories is currently locked in a legal battle in the United States to re-launch a cheaper version of the UK drugmaker's Suboxone Film.

Indivior also reiterated its full-year net revenues guidance of US$25 million to US$50 million from its new opioid addiction drug Sublocade, on which the company has pinned its hopes after the legal battles.

(Reporting by Arathy S Nair in Bengaluru; editing by Patrick Graham)

Source: Reuters

Bookmark